proEVLifeCycle Research and Training Network

EVER HEARD ABOUT "SINGLE EVs' HETEROGENEITY"?!?
In this review, our ESR5 Guillermo Bordanaba Florit from CIC bioGUNE Bilbao browses the current and prospective view about single-vesicle characterization methodologies, and the recent advances achieved in the field thanks to these technologies.

Check it out!! 😉 👇

https://lnkd.in/egUdvQps

Using single-vesicle technologies to unravel the heterogeneity of extracellular vesicles - Nature Protocols Understanding the heterogeneity of extracellular vesicles is crucial for unraveling their functions. This review describes the benefits, challenges and contributions of the state-of-the art methods used in single-vesicle analysis.

Last week proEVLifeCycle met again, this time in Barcelona! This time, apart from sharing our latest advances in and , our program included some more business-oriented sessions.
A huge thanks to all the speakers, particularly to keynote speakers: Pieter Vader, Javier Vega, PhD, Raymond Schiffelers, Michael Jones, Ramon Banet, Joël Jean-Mairet, Francesc E. Borràs, and Francisco Miguel Torres Grande.

ONLY ONE WEEK TO GO!! 🔥🔥🔥

November it's the "Prostate Cancer Awareness Month", and our proEVLifeCycle Project- H2020 MSCA ITN for Research on Extracellular Vesicles in Prostate Cancer Consortium is going to meet in person again, this time in the wonderful and vibrant city of Barcelona! 💃🏻🇪🇦

We will discuss our advancements in EV researches, focused on tackling Prostate Cancer, we will meet many researchers in the field and pitch our science in front of Industry experts!

We can't wait to meet, another amazing adventure is waiting for us!! 👨🏼‍🔬👩🏻‍🔬

Congratulations to our ESR9 Pedro Matos-Filipe from Anaxomics Biotech, who won the Ecopa Young Scientist Travel Award at the EUSAAT-Congress for his talk "Building virtual cohorts via the integration of public data".

The presentation focused on a new microarray data integration method, that focuses on the post-processing of public datasets. Using this new method, he and his team managed to produce Prostate Cancer patient dataset with a large number of samples. The same dataset was then applied to the field of biomarker discovery, which shed light onto new circulating biomarkers for high-grade Prostate Cancer detection.

We are very proud of you! 👏👏👏

It was wonderful to meet eachothers again in F2F and share these days in Paris 🇨🇵 with our ESRs and leading experts in the field of and .

Looking forward to the next meeting in November 2022, this time in... Barcelona!💃🏻🇪🇦